Skip to content
Head to head

UFP Technologies vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: UFPT · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

UFPT +30.5%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield.
UFPTABT
Snapshot
SectorMedical DevicesMedical Devices
Last price290.85103.00
Change today-2.70%-0.84%
1-year return+38.6%-15.4%
Market cap$2.25B$178.39B
52-week range173.86 – 342.1180.89 – 126.70
Valuation
P/E (TTM)29.7138.29
P/E percentile, own 5-yr range54th99th
P/B4.643.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)8.753.72
Net profit (TTM)$67.79M$6.44B
Revenue (TTM)$649.52M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+11.6%+14.5%
Gross margin28.9%56.9%
Operating margin15.4%13.8%
Net margin11.8%9.7%
Free cash flow (TTM)$63.51M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership117.0%81.2%
Insider activity (12mo)26 buy / 23 sell36 buy / 12 sell
Short interest (% of float)11.8%1.1%
Analyst consensus--93% buy / 7% hold (15)
Analyst price target--$122 (+18%)
StockVane view
StockVane Quant RatingC (77)D (22)
Company
Employees5,349115,000
Founded19631900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.